July 14-18 – Emerging Issues in Food and Drug Law (O’Neill Institute Summer Program with Confirmed Speakers)

By O’Neill Institute | Leave a Comment

Please join the O’Neill Institute for National and Global Health Law at Georgetown University for a one-week intensive summer institute exploring the domestic and international legal, regulatory, and policy framework shaping the safety and availability of foods and medicines worldwide.

The program will cover U.S. domestic law including recent laws and regulations; international regulatory harmonization and mutual recognition efforts now under way between major exporting and importing countries; and the increasing influence of trade and investment rules.  The program will convene leading academics, practitioners, and regulators to inform participants not only what the law is now, but which forces will shape its future.  Additional information can be found here.

Director

Professor Sam Halabi (HAL uh bee), J.D., M.Phil., is an O’Neill Institute Scholar and an Associate Professor at the University of Tulsa College of Law.  Between 2008 and 2010, he served as a Fellow at O’Neill and an Adjunct Professor of Law at Georgetown University Law Center. In 2008, he assisted the Presidential Health Care Policy Working Group on approaches to international food and drug inspections. In 2010, Professor Halabi addressed a special committee of the United Nations on the relationship between decentralized health care systems and social inclusion as well as the U.N. Committee on the Elimination of All Forms of Discrimination Against Women on Egypt’s compliance with the World Health Organization’s Framework Convention on Tobacco Control.

 He currently serves as the 2014 Director of the O’Neill Institute’s Summer Program on Emerging Issues in Food and Drug Law.  His recent policy work focuses on identifying and minimizing legal barriers to global vaccine availability. He is a member of the Editorial Board of the Food and Drug Law Journal as well as a member of the American Society of Law, Medicine and Ethics. His work has been published or is forthcoming in the Harvard International Law Journal, the Journal of Law, Medicine, and Ethics, the Michigan Journal of International Law, and the Northwestern Journal of International Law and Business, among others.

Confirmed Speakers

Alberto Alemanno, Jean Monnet Professor of EU Law and Risk Regulation, HEC-Paris

Parth Chanda, Senior Corporate Counsel, Compliance, Pfizer Pharmaceuticals

Philip Chen, Assistant General Counsel, Office of the US Trade Representative

Katherine Cooper, Associate Chief Counsel for International Affairs, US Food and Drug Administration

Jennifer Devine, Deputy Director, Global Regulatory Operations and Policy, US Food and Drug Administration

Michele Forzley, Senior Scholar and Careers and Externships Advisor, O’Neill Institute for National and Global Health Law, Distinguished Visiting Scholar, Health Law Institute, Widener University School of Law

Aliza Glasner, Institute Associate, O’Neill Institute for National and Global Health Law

Jesse Goodman, Director, Center on Medical Product Access, Safety and Stewardship (COMPASS), Georgetown University Medical Center, Former Chief Scientist, US Food and Drug Administration

Jeffrey Gren, Former Director, Office of Health and Consumer Goods, US Department of Commerce

Lisa Heinzerling, William J. Brennan, Jr. Professor of Law, Georgetown University Law Center, Former Associate Administrator, US Environmental Protection Agency Office of Policy, 2009-10

Susan C. Kim, Deputy Director, O’Neill Institute for National and Global Health Law

Benn McGrady, Project Director, Trade, Investment and Health Initiative, O’Neill Institute for National and Global Health Law, Adjunct Professor, Georgetown University Law Center

John Monahan, Senior Advisor to the President for Global Health and Senior Fellow, McCourt School of Public Policy, Georgetown University, Former Counselor to the Secretary and Director, Office of Global Health Affairs, US Department of Health and Human Services (HHS)

Joseph Page, Professor of Law, Georgetown University Law Center, Director, Center for the Advancement of the Rule of Law in the Americas

Gordon Schatz, Partner, Life Sciences Health Industry Group, Reed Smith, LLP

Marc Scheineson, Partner, Chair, Food and Drug Law Practice Group, Alston & Bird, LLP

Doug Stearn, Deputy Director Policy and Analysis, US Food and Drug Administration

David Vladeck, Professor of Law, Georgetown University Law Center, Former Director of the Bureau of Consumer Protection, Federal Trade Commission

Chris Waldrop, Director, Food Policy Institute, Consumer Federation of America

Timothy Westmoreland, Visiting Professor of Law, Georgetown University Law Center, Former Counsel to the Subcommittee on Health and the Environment, US Health of Representatives

Derek Yach, Senior Vice President of the Vitality Group, Former Executive Director for Noncommunicable Diseases and Mental Health, World Health Organization

Jennifer Zachary, Partner, Food and Drug Practice Group, Covington and Burling, LLP

 

Categories: FDA Global Health Health reform Healthcare Tobacco Trade uncategorized

Tags: FDA food and drug law FTC Medicines regulation